| Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method A Breier, TP Su, R Saunders, RE Carson, BS Kolachana, ... Proceedings of the National Academy of Sciences 94 (6), 2569-2574, 1997 | 1479 | 1997 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 1051 | 2017 |
| Simian virus-40 large-T antigen binds p53 in human mesotheliomas M Carbone, P Rizzo, PM Grimley, A Procopio, DJY Mew, V Shridhar, ... Nature medicine 3 (8), 908-912, 1997 | 337 | 1997 |
| Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion RE Carson, A Breier, A De Bartolomeis, RC Saunders, TP Su, B Schmall, ... Journal of Cerebral Blood Flow & Metabolism 17 (4), 437-447, 1997 | 270 | 1997 |
| Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism A De Bartolomeis, C Tomasetti, F Iasevoli CNS drugs 29, 773-799, 2015 | 208 | 2015 |
| Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depressive-like behavior via induction of Homer1a T Serchov, HW Clement, MK Schwarz, F Iasevoli, DK Tosh, M Idzko, ... Neuron 87 (3), 549-562, 2015 | 196 | 2015 |
| Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy F Iasevoli, M Fornaro, G D'Urso, D Galletta, C Casella, M Paternoster, ... Psychological medicine 51 (6), 1054-1056, 2021 | 182 | 2021 |
| Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant … F Iasevoli, S Giordano, R Balletta, G Latte, MV Formato, E Prinzivalli, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, 34-48, 2016 | 181 | 2016 |
| Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis V De Luca, DJ Mueller, A de Bartolomeis, JL Kennedy International Journal of Neuropsychopharmacology 10 (5), 697-704, 2007 | 154 | 2007 |
| An update of safety of clinically used atypical antipsychotics L Orsolini, C Tomasetti, A Valchera, R Vecchiotti, I Matarazzo, F Vellante, ... Expert opinion on drug safety 15 (10), 1329-1347, 2016 | 140 | 2016 |
| Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders … A de Bartolomeis, G Latte, C Tomasetti, F Iasevoli Molecular neurobiology 49, 484-511, 2014 | 135 | 2014 |
| Factors associated with real-life functioning in persons with schizophrenia in a 4-year follow-up study of the Italian network for research on psychoses A Mucci, S Galderisi, D Gibertoni, A Rossi, P Rocca, A Bertolino, ... JAMA psychiatry 78 (5), 550-559, 2021 | 134 | 2021 |
| Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation. KP Mohanakumar, A de Bartolomeis, RM Wu, KJ Yeh, LM Sternberger, ... Annals of the new York Academy of Sciences 738, 392-399, 1994 | 129 | 1994 |
| Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice F Guida, L Luongo, F Marmo, R Romano, M Iannotta, F Napolitano, ... Molecular brain 8, 1-15, 2015 | 128 | 2015 |
| The interplay among psychopathology, personal resources, context‐related factors and real‐life functioning in schizophrenia: stability in relationships after 4 years and … S Galderisi, P Rucci, A Mucci, A Rossi, P Rocca, A Bertolino, E Aguglia, ... World psychiatry 19 (1), 81-91, 2020 | 125 | 2020 |
| Transcranial direct current stimulation for obsessive–compulsive disorder: a randomized, controlled, partial crossover trial G D'Urso, AR Brunoni, MP Mazzaferro, A Anastasia, A de Bartolomeis, ... Depression and anxiety 33 (12), 1132-1140, 2016 | 112 | 2016 |
| Targeting the noradrenergic system in posttraumatic stress disorder: a systematic review and meta-analysis of prazosin trials DD Berardis, S Marini, N Serroni, F Iasevoli, C Tomasetti, ... Current drug targets 16 (10), 1094-1106, 2015 | 107 | 2015 |
| Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic … A de Bartolomeis, EF Buonaguro, F Iasevoli Psychopharmacology 225, 1-19, 2013 | 107 | 2013 |
| Permanent Focal Brain Ischemia Induces Isoform-Dependent Changes in the Pattern of Na+/Ca2+ Exchanger Gene Expression in the Ischemic Core, Periinfarct … F Boscia, R Gala, G Pignataro, A De Bartolomeis, M Cicale, ... Journal of Cerebral Blood Flow & Metabolism 26 (4), 502-517, 2006 | 107 | 2006 |
| A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia CU Correll, O Agid, B Crespo-Facorro, A de Bartolomeis, A Fagiolini, ... CNS drugs 36 (7), 659-679, 2022 | 106 | 2022 |
Elisabetta Filomena BuonaguroDpt Neuroscienze, Facoltà di Medicina Federico II, NapoliDirección de correo verificada de studenti.unina.it
